CVS director granted deferred stock units

CVS Health Corp director Larry Robbins reported an acquisition of deferred stock units as part of non-employee director compensation.

Rhea-AI Filing Summary

CVS Health Corp director Larry Robbins reported an acquisition of deferred stock units as part of non-employee director compensation. He received 1,930.0051 deferred stock units valued at $97.15 per unit, bringing his direct holdings of deferred stock units to 10,147.6418.

The award reflects a deferral of a semi-annual retainer under CVS Health’s 2017 Incentive Compensation Plan. Each deferred stock unit is designed to convert into one share of common stock, issuable when Robbins retires from the CVS Health Board of Directors, consistent with his deferral election.

Insider Trade Summary

Grant/Award: 1,930.0051 shares

Grant/Award 1 txn

Insider ROBBINS LARRY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	1,930.0051	$97.15	$187K

Holdings After Transaction: Deferred Stock Units — 10,147.6418 contracts (Direct)

Footnotes (2)

1. F1. Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan.
2. F2. Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.

Key Figures

Deferred stock units granted: 1,930.0051 units Grant valuation price: $97.15 per unit Total deferred stock units after grant: 10,147.6418 units +1 more

4 metrics

Deferred stock units granted 1,930.0051 units Director compensation grant on 2026-05-14

Grant valuation price $97.15 per unit Market price used for semi-annual retainer deferral

Total deferred stock units after grant 10,147.6418 units Direct holdings following reported transaction

Conversion ratio 1 unit = 1 share Each deferred stock unit converts into one CVS common share at retirement

Key Terms

Deferred Stock Units, semi-annual retainer, 2017 Incentive Compensation Plan, non-employee director compensation policy, +1 more

5 terms

Deferred Stock Units financial

"Consists of deferred stock units issued for deferral of a semi-annual retainer"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

semi-annual retainer financial

"issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy"

2017 Incentive Compensation Plan financial

"valued at the market price, pursuant to the 2017 Incentive Compensation Plan"

non-employee director compensation policy financial

"in connection with the Issuer's non-employee director compensation policy"

converted into one share of common stock financial

"each to be converted into one share of common stock and issued upon the Reporting Person's retirement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CVS (CVS) director Larry Robbins report?

Larry Robbins reported receiving deferred stock units as director compensation. He was granted 1,930.0051 deferred stock units tied to a semi-annual retainer, under CVS Health’s 2017 Incentive Compensation Plan, increasing his total deferred stock unit holdings to 10,147.6418.

How many CVS (CVS) deferred stock units did Larry Robbins acquire?

Larry Robbins acquired 1,930.0051 deferred stock units. These units represent deferred compensation for a semi-annual director retainer, valued at the market price of $97.15 per unit on the grant date, under CVS Health’s 2017 Incentive Compensation Plan.

What is Larry Robbins’ total CVS (CVS) deferred stock unit holding after this grant?

After the grant, Larry Robbins directly holds 10,147.6418 deferred stock units. This total reflects the new 1,930.0051-unit award added to his prior balance, as reported in the Form 4 insider filing for CVS Health Corp.

When will Larry Robbins’ CVS (CVS) deferred stock units convert into common stock?

Each deferred stock unit will convert into one share of CVS common stock upon Larry Robbins’ retirement from the Board. This timing is based on his election under the company’s non-employee director compensation policy and 2017 Incentive Compensation Plan.

How are CVS (CVS) deferred stock units for Larry Robbins valued?

The deferred stock units are valued at the market price of CVS common stock on the grant date. For this award, 1,930.0051 units were valued at $97.15 per unit, representing the deferred portion of a semi-annual director retainer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 05:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROBBINS LARRY

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	$0	05/14/2026		A(1)		1,930.0051		(2)	(2)	Common Stock	1,930.0051	$97.15	10,147.6418	D

Explanation of Responses:

1. Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan.

2. Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.

	/s/ Larry M. Robbins	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)